Loading STE detail
Loading ticker data...
Loading STE detail
STERIS plc provides infection prevention and other procedural products and services worldwide.
It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Chart data unavailable
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Somnigroup International Inc. (NYSE: SGI). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Somnigroup International stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Packaging Corporation of America (NYSE: PKG). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Packaging Corporation of America stock on March 17th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000
Representative April McClain Delaney (Democratic-Maryland) recently bought shares of Tractor Supply Company (NASDAQ: TSCO). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Tractor Supply stock on March 16th. Representative April McClain Delaney also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of
STE rides on strong Healthcare and AST growth, but FX swings, tariffs, and rising costs cloud the outlook for investors.
Aberdeen Group plc raised its stake in shares of STERIS plc (NYSE: STE) by 25.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 100,088 shares of the medical equipment provider's stock after purchasing an additional 20,097 shares
Assenagon Asset Management S.A. lowered its position in STERIS plc (NYSE: STE) by 94.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,742 shares of the medical equipment provider's stock after selling 312,165 shares during the period. Assenagon Asset Management S.A.'s holdings
Fast Retailing was a top contributor during the quarter, driven by strong execution across its global operations. Alibaba was a detractor during the quarter after the company reported mixed fiscal Q2 results. New positions were established in Sea Limited and Grab Holdings, while the portfolio's position in Atlassian was liquidated.
Cinctive Capital Management LP lowered its position in STERIS plc (NYSE: STE) by 12.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,615 shares of the medical equipment provider's stock after selling 2,741 shares during the period. Cinctive Capital Management
Focus Partners Advisor Solutions LLC grew its stake in shares of STERIS plc (NYSE: STE) by 149.1% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,573 shares of the medical equipment provider's stock after buying an additional 2,737 shares during the period.
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Davis R M Inc. decreased its holdings in STERIS plc (NYSE: STE) by 62.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,418 shares of the medical equipment provider's stock after selling 3,959 shares during the quarter. Davis R
Dana Investment Advisors Inc. increased its position in STERIS plc (NYSE: STE) by 688.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,712 shares of the medical equipment provider's stock after purchasing an additional 39,043 shares during the period. Dana Investment Advisors Inc.'s holdings
STERIS plc (NYSE: STE - Get Free Report) has received an average rating of "Moderate Buy" from the eight brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokerages
STERIS plc (NYSE: STE - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 1,560,494 shares, an increase of 22.7% from the January 15th total of 1,271,747 shares. Currently, 1.6% of the company's stock are sold short. Based
STERIS (NYSE: STE - Get Free Report) and QHSLab (OTCMKTS:USAQ - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Valuation and Earnings This table compares STERIS and QHSLab"s gross
